Terence Flynn

Q: What is Terence Flynn's success rate?

Terence Flynn currently has a success rate of 81.83663609083509.

Q: What is the average return of Terence Flynn's calls?

Their stock ratings have generated an average return of 20.330218771000602.

Morgan Stanley | Healthcare

Terence Flynn is an analyst from Morgan Stanley specializing in the Healthcare sector. Ranked #1398 out of 4508 analysts, they have issued 60 stock ratings with a success rate of 81.84% and an average return of 20.33%.

Terence Flynn has a well-established track record, with 60 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 81.84% and an average return of 20.33%, underscoring their expertise and ability to identify winning opportunities for investors.

#1398

Out of 4508

Total Ratings

+81.84%

Success Rate

+20.33%

Average Return

Recent Ratings Analysis

RCUS

Hold

Jan 08, 2026

Target

$23.00

Current

$21.01

Performance

-1.59%

Terence Flynn rated RCUS as Equal-Weight on Jan 08, 2026, setting a price target of 23. The Hold stance appears justified, as shares hovered around 21.01 with a -1.59% move.

NRIX

Buy

Jan 08, 2026

Target

$36.00

Current

$19.30

Performance

3.60%

On Jan 08, 2026, NRIX was given a Overweight rating by Terence Flynn, with a target price of 36. The stock traded sideways with a 3.60% move, keeping the bullish thesis unresolved.

ALMS

Buy

Jan 07, 2026

Target

$33.00

Current

$19.56

Performance

9.15%

ALMS received a Overweight rating from Terence Flynn on Jan 07, 2026, aiming for 33. Momentum has favored the Buy call, with shares climbing from 19.56 to 19.56, rewarding those who trusted the recommendation.

BHVN

Buy

Jan 06, 2026

Target

$26.00

Current

$11.11

Performance

15.49%

On Jan 06, 2026, Terence Flynn published a Overweight outlook on BHVN, with a target of 26. Shares gained 15.49%, underscoring the accuracy of the bullish outlook toward 26.

PFE

Hold

Dec 17, 2025

Target

$28.00

Current

$25.48

Performance

1.76%

Terence Flynn on Dec 17, 2025 assigned PFE a Equal-Weight rating, with a price target of 28. The Hold stance reflected consolidation, as shares held near 25.48.

ABBV

Buy

Dec 12, 2025

Target

$269.00

Current

$220.08

Performance

-1.45%

On Dec 12, 2025, Terence Flynn reaffirmed ABBV with a Overweight rating, targeting 269. Market indecision has kept the 269 target in a holding pattern.

AMGN

Hold

Dec 12, 2025

Target

$329.00

Current

$326.10

Performance

2.63%

AMGN was rated Equal-Weight by Terence Flynn on Dec 12, 2025, with a price objective of 329. Flat performance suggests the Hold view was reasonable.

BMY

Sell

Dec 12, 2025

Target

$37.00

Current

$55.86

Performance

6.58%

On Dec 12, 2025, Terence Flynn initiated coverage on BMY with a Underweight rating and target of 37. The rating correctly identified downside risks, with the stock losing 6.58%.

GPCR

Buy

Dec 12, 2025

Target

$125.00

Current

$68.61

Performance

2.31%

Terence Flynn issued a Overweight recommendation for GPCR on Dec 12, 2025, price target set at 125. The target of 125 remains in play, though confirmation will depend on future moves.

JNJ

Hold

Dec 12, 2025

Target

$197.00

Current

$204.39

Performance

-3.40%

On Dec 12, 2025, JNJ was evaluated by Terence Flynn, who gave a Equal-Weight rating and target of 197. Hold sentiment was validated by subdued trading with no breakout beyond 204.39.

MRK

Hold

Dec 12, 2025

Target

$102.00

Current

$110.53

Performance

10.20%

Terence Flynn rated MRK as Equal-Weight on Dec 12, 2025, setting a price target of 102. Despite the Hold call, shares climbed 10.20% to 110.53, revealing unexpected momentum.

VRTX

Buy

Dec 05, 2025

Target

$564.00

Current

$463.86

Performance

1.84%

On Dec 05, 2025, VRTX was given a Overweight rating by Terence Flynn, with a target price of 564. The stock traded sideways with a 1.84% move, keeping the bullish thesis unresolved.

LLY

Buy

Nov 24, 2025

Target

$1290.00

Current

$1063.56

Performance

-0.62%

LLY received a Overweight rating from Terence Flynn on Nov 24, 2025, aiming for 1290. Price action was muted, as shares hovered around 1063.56 despite the bullish outlook.

OGN

Hold

Nov 11, 2025

Target

$9.00

Current

$8.05

Performance

7.05%

On Nov 11, 2025, Terence Flynn published a Equal-Weight outlook on OGN, with a target of 9. The Hold call missed some of the bullish momentum as shares advanced toward 9.

RPRX

Buy

Oct 10, 2025

Target

$54.00

Current

$40.17

Performance

11.55%

Terence Flynn on Oct 10, 2025 assigned RPRX a Overweight rating, with a price target of 54. The Buy call aligned well with market performance, producing a gain of 11.55%.

BNTX

Buy

Oct 10, 2025

Target

$131.00

Current

$99.85

Performance

-2.17%

On Oct 10, 2025, Terence Flynn reaffirmed BNTX with a Overweight rating, targeting 131. Market indecision has kept the 131 target in a holding pattern.

UTHR

Hold

Oct 10, 2025

Target

$435.00

Current

$483.23

Performance

9.83%

UTHR was rated Equal-Weight by Terence Flynn on Oct 10, 2025, with a price objective of 435. Despite caution, upside momentum rewarded risk-takers with gains to 483.23.

ARVN

Hold

Mar 13, 2025

Target

$12.00

Current

$12.07

Performance

41.17%

On Mar 13, 2025, Terence Flynn initiated coverage on ARVN with a Equal-Weight rating and target of 12. The Hold stance underestimated the stock’s strength as it gained 41.17%.

CRSP

Sell

Feb 14, 2025

Target

$32.00

Current

$53.84

Performance

8.29%

Terence Flynn issued a Underweight recommendation for CRSP on Feb 14, 2025, price target set at 32. The bearish outlook played out, as shares fell from 53.84 to 53.84.

NTLA

Hold

Jan 27, 2025

Target

$11.00

Current

$10.38

Performance

-1.61%

On Jan 27, 2025, NTLA was evaluated by Terence Flynn, who gave a Equal-Weight rating and target of 11. Hold sentiment was validated by subdued trading with no breakout beyond 10.38.

BPMC

Buy

May 06, 2024

Target

$168.00

Current

$129.46

Performance

21.84%

Terence Flynn rated BPMC as Buy on May 06, 2024, setting a price target of 168. The call has proven timely, with shares rising 21.84% toward the price target of 168.

Frequency Asked Questions

Who is Terence Flynn?

Terence Flynn is an analyst from Morgan Stanley specializing in the Healthcare sector.

What is Terence Flynn's success rate?

Terence Flynn currently has a success rate of +81.84%.

How many ratings has Terence Flynn issued?

Terence Flynn has issued 60 stock ratings so far.

What is the average return of Terence Flynn's calls?

Their stock ratings have generated an average return of +20.33%.

What is Terence Flynn's ranking?

Terence Flynn is ranked #1398 out of 4508 analysts.

What types of ratings does Terence Flynn give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Terence Flynn?

You can follow Terence Flynn by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Terence Flynn?

Their latest rating was a Hold on RCUS issued on 2026-01-08.